Reeve Emma 4
4 · PTC THERAPEUTICS, INC. · Filed Oct 31, 2025
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Sale
Common Stock
2025-10-30$69.50/sh−12,000$834,000→ 6,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-30−12,000→ 0 totalExercise: $38.10Exp: 2032-01-06→ Common Stock (12,000 underlying) - Sale
Common Stock
2025-10-30$69.50/sh−3,666$254,787→ 6,666 total - Exercise/Conversion
Common Stock
2025-10-30$38.10/sh+12,000$457,200→ 18,666 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.
- [F2]Currently exercisable.